Latest / Pharmacy Podcast Network / Cannabidiol (CBD) Primer for Pharmacists Presented by Stephen B. Corn, MD & Meredith Fisher-Corn, MD | The Answer Page Podcast
Transcript
- 0:05Speaker 1: You are listening to the global network of podcasters dedicated
- 0:09Speaker 1: to the pharmacy profession. Welcome to the Pharmacy podcast Network.
- 0:27Speaker 2: The Answer Page podcast is an educational resource that produces
- 0:31Speaker 2: the highest quality, accredited cannabis content for pharmacists, doctors, nurses,
- 0:35Speaker 2: and all healthcare providers and caregivers.
- 0:38Speaker 3: Founders Stephen B. Korn, MD and Meredith fishercorn, MD discuss
- 0:43Speaker 3: relevant and cutting edge topics focused on pain, medicine, opioid use,
- 0:47Speaker 3: the endocannabinoid system, and cannabinoid based medicine for healthcare providers, caregivers,
- 0:53Speaker 3: patients in those interested in cannabinoid science. This is the
- 0:57Speaker 3: Answer Page Podcast.
- 0:59Speaker 4: CBD is a hot topic. Some patients may be interested
- 1:01Speaker 4: in CBD products to determine if it would help alleviate
- 1:04Speaker 4: one or more of their ailments or simply enhance their
- 1:06Speaker 4: overall quality of life. These patients may have questions about
- 1:10Speaker 4: the therapeutic use of CBD, as well as how to
- 1:12Speaker 4: judge the quality of commercial CBD products. This podcast will
- 1:16Speaker 4: provide pharmacists and other healthcare providers with relevant, peer reviewed
- 1:19Speaker 4: information to assist in the guidance of their patients.
- 1:22Speaker 5: Hey, welcome back. This is the Answer Page podcast. The
- 1:26Speaker 5: Answer Page dot com is a medical education resource founded
- 1:30Speaker 5: by doctor Stephen Korn and doctor Meredith Fishercorn. They've been
- 1:35Speaker 5: providing the highest quality of accredited education to healthcare communities
- 1:39Speaker 5: for over two decades. We are so pleased to have
- 1:42Speaker 5: them as part of the Pharmacy Podcast Network. They've been
- 1:46Speaker 5: awarded in the US and internationally. The Answer Page is
- 1:50Speaker 5: now a recognized leader for providing multi accredited comprehensive education
- 1:55Speaker 5: on the endocannabinoid system and medical cannabis, pain medicine, and
- 2:01Speaker 5: opioid prescribing practices. Steven and Meredith, it's great to see
- 2:06Speaker 5: you again.
- 2:07Speaker 6: Thank you, thanks so much. Thanks for always having us.
- 2:10Speaker 6: It's always a pleasure to be on the Pumaca podcast network.
- 2:14Speaker 6: So today we thought we would present a cannabid dial
- 2:17Speaker 6: prime of healthcare providers with a focus that should be
- 2:21Speaker 6: really relevant for pharmacists to begin. Some patients may be
- 2:26Speaker 6: interested in trying a CBD product to determine if it
- 2:30Speaker 6: would help alleviate one or more of their ailments but
- 2:33Speaker 6: simply enhance their overall quality of life. These patients may
- 2:37Speaker 6: have questions about the therapeutic use of CBD, as well
- 2:40Speaker 6: as how to judge the quality of commercial CBD products.
- 2:44Speaker 6: Some patients are reluctant to ask their healthcare providers, and
- 2:47Speaker 6: many healthcare providers are not familiar with cannabinoid based therapeutics
- 2:52Speaker 6: because they never received formal education on the topic during
- 2:55Speaker 6: their training. Today, we will address these relevant issues and
- 2:59Speaker 6: provide access to the answer page dot com free educational,
- 3:04Speaker 6: gear reviewed resources, as well as discounts to our multi
- 3:08Speaker 6: accredited courses. For any of our multi accredited courses, simply
- 3:12Speaker 6: use discount code PPN ten Think Pharmacy Podcast Network ten
- 3:17Speaker 6: for any of the answer page dot Com course and
- 3:20Speaker 6: receive a tempescent discount. The handouts I want to call
- 3:23Speaker 6: your attention to which I think are really relevant. They're
- 3:26Speaker 6: free educational handouts. Anyone can get them. You can use
- 3:29Speaker 6: them for your own learning. They're also really good to
- 3:31Speaker 6: share with patients and explain things. The first is the
- 3:35Speaker 6: endocan abinoid system and medical marijuana in fifteen minutes. It
- 3:40Speaker 6: really takes someone who knows very little to nothing about
- 3:43Speaker 6: this and brings them really up to speed, very very quickly.
- 3:47Speaker 6: It's really really proud of this. I think it's a
- 3:49Speaker 6: great resource. The other, which may be particularly relevant to
- 3:53Speaker 6: pharmacists is our perioperative considerations for products for patients utilizing
- 3:58Speaker 6: cannabinoid based medicines and products. It's it goes through drug
- 4:04Speaker 6: drug interactions. It lists interactions with anesthetic drugs and explains
- 4:10Speaker 6: things that are really relevant for the perioperative period, including
- 4:13Speaker 6: the post operative period in terms of pain control. And
- 4:17Speaker 6: then we have a primer, a Cannabi dial Prime Essential
- 4:21Speaker 6: information for healthcare providers and consumers. A lot of that
- 4:24Speaker 6: information will parallel what we're discussing today, but it's it's
- 4:29Speaker 6: a great resource to share with patients and other colleagues.
- 4:33Speaker 6: So in terms of use of CBD products, so doctor
- 4:36Speaker 6: Fisher Korn, is any guidance related to the quality standards
- 4:40Speaker 6: of CBD products purchased online, in a retail store at
- 4:44Speaker 6: a doctor's office. It's really important that patients know what
- 4:47Speaker 6: they're getting. So what criteria should a patient use when
- 4:51Speaker 6: selecting a CBD product?
- 4:53Speaker 7: Oh, that's a great question. We get that a lot.
- 4:56Speaker 8: So according to the Clinician's Guide the Cannabi diesile and
- 5:00Speaker 8: hemp Oils that was published in an edition of the
- 5:03Speaker 8: Mayo Clinic Proceedings, one should follow certain steps. For example,
- 5:08Speaker 8: you have to determine if the product has been extracted
- 5:11Speaker 8: by carbon dioxide with no solvents. You also need to
- 5:15Speaker 8: determine if it's certified by the US Department of Agriculture
- 5:19Speaker 8: as organic, and you also have to confirm that it's
- 5:23Speaker 8: been tested for pesticides and herbicides. The Mayo Clinic and
- 5:27Speaker 8: other healthcare establishments have requirements for collaboration with manufacturers of
- 5:32Speaker 8: dietary supplements, and the basis of some of these standards
- 5:36Speaker 8: can be applied to the purchase of CBD products. The
- 5:40Speaker 8: standards include some of the following points. Doesn't meet the
- 5:44Speaker 8: standards of current good Manufacturing practices, certification from the US
- 5:50Speaker 8: Food and Drug Administration, from the European Union, from the
- 5:55Speaker 8: Australian Union, or from the Canadian Organic Certification And also
- 6:03Speaker 8: you need to determine does the company have an independent
- 6:07Speaker 8: adverse event reporting program. The fact that it's an independent
- 6:12Speaker 8: adverse event reporting program is very important.
- 6:15Speaker 7: You also need to.
- 6:16Speaker 8: Determine is the product certified organic or EGO farmed. And finally,
- 6:23Speaker 8: have their products been laboratory tested by batch to confirm
- 6:27Speaker 8: THHC levels are less than zero point three percent and
- 6:32Speaker 8: the product contains no pesticides or heavy metals.
- 6:36Speaker 5: I've seen on labels a certificate of analysis. So how
- 6:44Speaker 5: does an individual find out if there are pesticides or
- 6:47Speaker 5: heavy metals in any of the CBD products that are
- 6:50Speaker 5: out there.
- 6:52Speaker 6: It's a great question. CBD manufacturers may provide a certificate
- 6:56Speaker 6: of analysis, Doctor Fisher Cohn is a certificate of analysis.
- 7:01Speaker 6: Since Todd brings us up, it's a great time to
- 7:03Speaker 6: get into this and what information is typically included on
- 7:06Speaker 6: a certificate analysis?
- 7:07Speaker 8: Okay, So the certificate of analysis is basically like a
- 7:11Speaker 8: lab report, and it's performed, and it should be performed
- 7:15Speaker 8: by an accredited, independent, third party laboratory, and it should
- 7:21Speaker 8: provide a detailed analysis of the CBD product. A certificate
- 7:27Speaker 8: of analysis, often referred to as the CoA, is essential
- 7:32Speaker 8: to verifying the purity and the potency of a product.
- 7:36Speaker 8: For example, a CoA reports the amount of CBD in
- 7:40Speaker 8: the product, and it should The amount is often described
- 7:44Speaker 8: in miligrams per mL or milligrams per gram. It should
- 7:48Speaker 8: also on the certificate of analysis. It should also indicate
- 7:52Speaker 8: the amount of THC if there is any, and the
- 7:56Speaker 8: other cannabinoids in the product. The presents of excipient should
- 8:01Speaker 8: be indicated. The presence of microbials including salmonella, and also
- 8:07Speaker 8: the presence of pesticides and there should be it should
- 8:12Speaker 8: the CoA should indicate if there are molds or yeast
- 8:17Speaker 8: or microtoxins produced by the mold, and also if heavy
- 8:22Speaker 8: metals are present, including arsenic, cadmium, lead, mercury, and if
- 8:27Speaker 8: there's a presence of solvents. Potency and impurity content data
- 8:33Speaker 8: should also be listed and an expiration date should be
- 8:36Speaker 8: listed and the testing methods. A lot goes into a
- 8:40Speaker 8: certificate of analysis.
- 8:42Speaker 6: Noah, you're right, that's a lot of information, and that's
- 8:44Speaker 6: a lot of detailed information. You would hope it's based
- 8:47Speaker 6: on formal testing. How do you know if the certificate
- 8:50Speaker 6: analysis is real? Is? How do you know if it's valid?
- 8:53Speaker 7: Oh? Another great question.
- 8:56Speaker 8: One way to establish the authenticity of a certificate of
- 8:59Speaker 8: analysis is to contact the issuing lab. If an accredited
- 9:03Speaker 8: lab is not listed on the CoA, then the CoA
- 9:07Speaker 8: is not valid. Also, the CBD manufacturer should not be
- 9:12Speaker 8: conducting the analysis of the product and should have no
- 9:15Speaker 8: influence on the results of the report.
- 9:19Speaker 6: So it's a great report and important to report. We
- 9:22Speaker 6: know now how to validated? Where do you find it.
- 9:28Speaker 8: A CoA can often be obtained by scanning the QR
- 9:31Speaker 8: code on the packaging of the product or from the
- 9:34Speaker 8: manufacturer's website.
- 9:36Speaker 6: Okay, good, that really helps a lot. CBD oil products,
- 9:41Speaker 6: I know maybe sold as full spectrum, broad spectrum CBD
- 9:45Speaker 6: isolate and whole plant CBD A lot of words. What
- 9:50Speaker 6: is the difference among the four types?
- 9:52Speaker 8: That's another popular question. So full spectrum is exactly what
- 9:57Speaker 8: it says. It's full spectrum. Full spectrum CBD extracts contain
- 10:05Speaker 8: CBD as well as other cannabinoids, including up to zero
- 10:10Speaker 8: point three percent THHC, also terpenes and essential oils. Unlike
- 10:16Speaker 8: full spectrum CBD, broad spectrum CBD does not contain THHC,
- 10:23Speaker 8: but it does contain the other components that are found
- 10:26Speaker 8: in full spectrum CBD. And CBD isolate is exactly what
- 10:31Speaker 8: it says. It's an isolate. It's typically sold as ninety
- 10:35Speaker 8: nine percent plus pure CBD. And then you also asked
- 10:39Speaker 8: about whole plant CBD. Whole plant CBD is similar to
- 10:44Speaker 8: full spectrum CBD as it contains a variety of the cannabinoids,
- 10:48Speaker 8: the terpenes, and the essential oils.
- 10:50Speaker 7: However, whole plants.
- 10:51Speaker 8: CBD also contains fats, waxes, and other fibrous materials.
- 10:57Speaker 6: That's a great way of breaking it down. CBD products
- 11:01Speaker 6: that purchase online labeled accurately, how would one know?
- 11:05Speaker 8: Yeah, sometimes they're labeled accurately and sometimes they're not so.
- 11:10Speaker 8: In twenty seventeen, a study evaluating the accuracy of the
- 11:14Speaker 8: labels of CBD extracts that had been purchased online was performed.
- 11:20Speaker 8: The study looked at the CBD content and other cannabinoid
- 11:23Speaker 8: content of eighty four CBD products and they were manufactured
- 11:28Speaker 8: by thirty one different US companies. In approximately forty three
- 11:33Speaker 8: percent of the products, the CBD content was under reported,
- 11:38Speaker 8: and in twenty six percent of the products, the CBD
- 11:41Speaker 8: content was over reported, and in thirty one percent of
- 11:46Speaker 8: the products, the CBD content was accurately reported. But of note,
- 11:52Speaker 8: THCHC was detected in about a fifth in twenty one
- 11:57Speaker 8: percent of the samples, but the labels didn't indicate that
- 12:00Speaker 8: THC was in the product. And furthermore, the amount of
- 12:04Speaker 8: THC and the products could potentially cause intoxication or impairment.
- 12:10Speaker 6: That's very important because that can affect patients in many
- 12:13Speaker 6: different ways. In the workplace at home in terms of functioning,
- 12:16Speaker 6: that's really incredibly important to know.
- 12:19Speaker 5: Yes, I agree, absolutely. We hear a lot of feedback
- 12:24Speaker 5: from our pharmacists out there and pharmacy owners for that matter,
- 12:28Speaker 5: where they'll have patients come in and have moved their
- 12:34Speaker 5: prescriptions and moved their business from one organization, one pharmacy
- 12:39Speaker 5: to another, and have brought up, Hey, my employer tests
- 12:44Speaker 5: for marijuana or cannabis in my system, and if you're
- 12:49Speaker 5: taking a CBD product, you have to be rest assured
- 12:52Speaker 5: that there isn't going to be any THC in it,
- 12:54Speaker 5: especially for those issues of testing. And I want to
- 12:58Speaker 5: kind of ask another their question that I was thinking
- 13:01Speaker 5: as you were talking, and that is, you know, what
- 13:03Speaker 5: are the common reasons why patients are trailing or buying
- 13:08Speaker 5: or using CBD.
- 13:12Speaker 8: So consumers use CBC in forms, whether it's topical gummies
- 13:19Speaker 8: or tinctures, and for topical use, consumers primarily use CBD
- 13:27Speaker 8: to manage pain, whether it's joint stiffness, tendinitis, or muscle soreness,
- 13:33Speaker 8: or they could be using it for dermatological conditions such
- 13:36Speaker 8: as acne, dermatitis, and ezema. But these products are sometimes
- 13:42Speaker 8: used for cosmetic purposes too, for example anti aging. And
- 13:47Speaker 8: then some patients use CBD gummies or tinctures and they'll
- 13:52Speaker 8: use it for anxiety, sleep, pain, gilments, cognition, mood, and
- 13:58Speaker 8: decrease inflammation.
- 14:00Speaker 7: And some just use it for overall well being.
- 14:03Speaker 6: Yes, now I have another question which I think could
- 14:06Speaker 6: be interesting. What is some of the proposed ways of
- 14:09Speaker 6: which CBD may potentially help athletes feel better?
- 14:14Speaker 8: So, according to some studies, the consumption of CBD may
- 14:19Speaker 8: improve sleep, reduce anxiety and depression, decrease inflammation, reduce muscle
- 14:25Speaker 8: pain and soreness, and enhance recovery. So there have been
- 14:29Speaker 8: several articles that athletes are trying CBD to help improve
- 14:34Speaker 8: their performance.
- 14:37Speaker 5: We've really been thirsty for this kind of information. On
- 14:40Speaker 5: the Pharmacy podcast Network, pharmacists are listening, Pharmacy technicians are listening,
- 14:46Speaker 5: Pharmacy business people are listening. So with the pharmacists in particular,
- 14:52Speaker 5: shout out to you. You guys are my favorite providers.
- 14:55Speaker 5: Let's talk about the clinical considerations. I definitely want to
- 15:00Speaker 5: hone in on that.
- 15:02Speaker 6: Okay, So I think we should start off with a
- 15:04Speaker 6: very significant issue, which is respiratory depression and respiratory arrest.
- 15:10Speaker 6: Doctor Fisher, Korn and I have created a lot of
- 15:12Speaker 6: content on the opioid epidemic concerns about the primary issue
- 15:16Speaker 6: with that, which is respiratory arrest. And we know opioids
- 15:22Speaker 6: and benzodiazepines may lead to respiratory depression. So doctor Fisher
- 15:26Speaker 6: corn the CBD lead to respiratory depression.
- 15:29Speaker 8: So the consumption of CBD has not been associated with
- 15:34Speaker 8: respiratory depression because it doesn't bind to the cells and
- 15:37Speaker 8: the respiratory center of our brains. However, the quality and
- 15:42Speaker 8: purity of CBD products can vary widely, as we discussed earlier,
- 15:46Speaker 8: and contaminants and or mislabeling could then introduce risks, including
- 15:52Speaker 8: respiratory depression.
- 15:54Speaker 6: So the important point is, you know CBD in and
- 15:56Speaker 6: of itself is not going to cause respiratory depression by
- 15:59Speaker 6: now binding to the rest inspiratory center. But you've got
- 16:01Speaker 6: to make sure you have a quality product so that
- 16:04Speaker 6: it doesn't have contaminants that could cause adverse events exactly
- 16:08Speaker 6: beyond the CB, beyond your expectations for the CBD. So
- 16:11Speaker 6: opioids and benzo azepines can be addictive. Is CBD addictive?
- 16:16Speaker 6: Does it does the abrupt discontinuation of CBD use lead
- 16:20Speaker 6: to withdrawal symptoms.
- 16:23Speaker 8: So, in twenty twenty, a study evaluating abuse liability of CBD.
- 16:30Speaker 7: Found that CBD is.
- 16:32Speaker 8: Not addictive and the abrupt withdrawal of CBD after four
- 16:37Speaker 8: weeks of use at seven hundred and fifty milligrams twice
- 16:41Speaker 8: daily taken orally and that's a high dose, did not
- 16:44Speaker 8: result in any symptoms of physical withdrawal. But for individuals
- 16:49Speaker 8: who have a seizure disorder and are using CBD to
- 16:53Speaker 8: control the seizures, the CBD products should not be abruptly discontinued.
- 16:58Speaker 8: Similar to other seizure medicas, the CBD should be tapered.
- 17:02Speaker 8: And also you need to keep in mind that CBD
- 17:06Speaker 8: does interact with many of the commonly prescribed seizure medications,
- 17:10Speaker 8: so as the CBD is tapered, the levels of the
- 17:13Speaker 8: other seizure medications need to be monitored.
- 17:17Speaker 6: So when teaching our residents, when teaching other colleagues, when
- 17:22Speaker 6: instructing patients, we want to be exact in our terminology,
- 17:25Speaker 6: and that doesn't always occur in medicine. The words you
- 17:28Speaker 6: used properly so often stated that CBD is not psychoactive.
- 17:33Speaker 6: You hear that all the time, and THC is psychoactive
- 17:37Speaker 6: with doctor Fisher coen when you say that's an accurate statement.
- 17:40Speaker 6: Is CBD psychoactive?
- 17:42Speaker 8: Actually, both THC and CBD are psychoactive. By definition, a
- 17:49Speaker 8: psychoactive drug is a substance that acts on the central
- 17:53Speaker 8: nervous system where it all the just brain function and
- 17:56Speaker 8: neurotransmitter function, resulting in temporary changes in reception, mood, consciousness,
- 18:02Speaker 8: and behavior. But unlike THC, CBD does not induce that
- 18:08Speaker 8: euphoric feeling, you know, the high that you get from
- 18:12Speaker 8: consuming THC and CBD does not induce hallucinations. But as
- 18:18Speaker 8: we've discussed earlier, CBD does help with sleep and overall mood.
- 18:24Speaker 8: So yes, CBD is psychoactive.
- 18:28Speaker 6: Very important distinction, there's ingesting CBD with lipids. Different meals
- 18:34Speaker 6: lipids impact the absorption of CBD.
- 18:37Speaker 8: Surprisingly, yes, and it's significant according to clinical studies evaluating
- 18:44Speaker 8: the metabolism of a CBD product, Consuming CBD with lipids
- 18:48Speaker 8: may enhance the absorption of CBD and increased CBD.
- 18:52Speaker 7: Levels by up to four to five times.
- 18:55Speaker 6: That's significant. That's very significant, yes, And also for our pharmacist,
- 19:00Speaker 6: I was kind of a dial metabolized.
- 19:02Speaker 8: Well, most of our information about CBD metabolism comes from
- 19:09Speaker 8: the FDA approved product called Epidialects, which is an anti
- 19:13Speaker 8: seizure medication. And what they found in those trials is
- 19:19Speaker 8: that CBD is extensively metabolized in the liver by the
- 19:23Speaker 8: cytochrome P four fifty enzymes CYP three A four and
- 19:28Speaker 8: CYP two C nineteen. CBD metabolites are excreted in feces
- 19:34Speaker 8: and in urine, and CBD has a high volume of distribution,
- 19:38Speaker 8: and similar to THC, CBD is lipophilic and accumulates in
- 19:42Speaker 8: atipost issues.
- 19:44Speaker 5: Just for our listener's sake as well. Back to the
- 19:46Speaker 5: lipids and digestion. And so you have made the comment
- 19:51Speaker 5: that if you're eating something specific and taking CBD at
- 19:56Speaker 5: the same time, it will enhance the impact of CBD.
- 20:01Speaker 5: So is that fatty food? Is that sugar?
- 20:06Speaker 7: Like?
- 20:06Speaker 5: What food would we eat on purpose with a CBD
- 20:11Speaker 5: in order to get the maximum value out of it?
- 20:15Speaker 7: Well, weapids are facts.
- 20:17Speaker 8: So it's the fatty foods, it's the French fries, it's
- 20:21Speaker 8: the you know, it's the fatty oil food.
- 20:24Speaker 6: And it's also that one may not want to necessarily
- 20:27Speaker 6: do that to get a quick absorption. I mean, you
- 20:29Speaker 6: want to get on a regime that you're comfortable with
- 20:32Speaker 6: and then so to keep that and then slowly modify it.
- 20:35Speaker 6: So we're not recommending that someone just immediately takes CBD
- 20:39Speaker 6: with a faty meal to get a quick uptake and distribution.
- 20:43Speaker 6: You really want to get on the regime, get comfortable
- 20:45Speaker 6: with it, and then alter it. It was more to
- 20:48Speaker 6: point out that this can significantly change the absorption of CBD.
- 20:52Speaker 7: Excellent point, doctor Coin, excellent.
- 20:56Speaker 6: Okay, So now let's switch to some info on drug
- 20:59Speaker 6: drug interactions as we get near the end of this podcast.
- 21:02Speaker 6: So one of the courses that i'll say Merritt doctor
- 21:05Speaker 6: Fisher Khan had written for the answer page dot com.
- 21:07Speaker 6: It's called CBD and Clinical Care. I know that you
- 21:11Speaker 6: review drug drug interactions in detail in that course. For example,
- 21:14Speaker 6: there's a discussion on drug drug interactions between CBD and
- 21:18Speaker 6: enzyme substrates inhibitus induces of CYP three A four and
- 21:23Speaker 6: CYP two C nineteen. But not going to have the
- 21:26Speaker 6: opportunity to review them in this short podcast. They are
- 21:29Speaker 6: on the course, but there are especially some noteworthy drug
- 21:32Speaker 6: drug interactions I'd like to hit on today, So can
- 21:35Speaker 6: you discuss a few?
- 21:37Speaker 8: Sure, There's actually three that I'd like to highlight. The
- 21:40Speaker 8: first one is CBD and warfarin. CBD's inhibition of CYP
- 21:46Speaker 8: two C nineteen can increase levels of warfin, and multiple
- 21:51Speaker 8: reports have indicated that the interaction between morphin and CBD
- 21:56Speaker 8: result in a greatly increased risk of bleeding. The second
- 22:01Speaker 8: one that I wanted to highlight is CBD and methodone.
- 22:05Speaker 8: CBD inhibits CYP three A four as well as CYP
- 22:10Speaker 8: two C nineteen, and both of these enzymes are involved
- 22:14Speaker 8: in metabolism of methodone, So the co administration of methodone
- 22:19Speaker 8: in CBD can lead to significant sedation. And there have
- 22:23Speaker 8: been multiple case reports where patients are taking CBD without
- 22:29Speaker 8: telling their doctors and then the doctors prescribe methodone and
- 22:34Speaker 8: the patients end up being significantly more sedated than expected.
- 22:39Speaker 8: So the third drug drug interaction that I wanted to
- 22:42Speaker 8: mention is CBD and anti epileptic drugs. The code administration
- 22:47Speaker 8: of CBD and anti seizure medications is associated with significant
- 22:52Speaker 8: increases in serum levels of several seizure medications. And the
- 22:57Speaker 8: dosages of the seizure medication may need to be adjusted
- 23:01Speaker 8: when either you initiate the CBD therapy or even if
- 23:05Speaker 8: you just change the doseph the CBD therapy.
- 23:09Speaker 5: All Right, this was really interesting packed with a lot
- 23:13Speaker 5: of great information. A shout out to our listeners. In
- 23:17Speaker 5: the show notes, we are going to have a link
- 23:19Speaker 5: to the course that doctor Meredith Fisher Korn mentioned, the
- 23:23Speaker 5: Drug Drug Interactions course. We really want our pharmacists to
- 23:27Speaker 5: tap into that and once again use code PPN ten
- 23:33Speaker 5: to get ten percent off of your course that you
- 23:36Speaker 5: purchase through the answer page. Once again, it's the answer
- 23:40Speaker 5: page dot com. Meredith and Steven, this has been wonderful
- 23:45Speaker 5: to have you back on the Pharmacy Podcast Network guiding
- 23:48Speaker 5: our providers, our pharmacists out there with the best leverage
- 23:52Speaker 5: and usage of CBD and PHC. We can't wait to
- 23:56Speaker 5: have you back.
- 23:57Speaker 6: Thank you very much. It's always a pleasure to be
- 23:59Speaker 6: on the Pharmacy Podcast Network.
- 24:01Speaker 7: Thanks very much.
- 24:02Speaker 8: Take care, Thank you.